Search for Clinical Trial Results

Embryonal Carcinoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Condition:
Interventions: Drug: Brentuximab Vedotin Both cohorts will be treated similarly and in parallel but analyzed separately |
Completed |
Study Name: Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Condition:
|
Recruiting |
Study Name: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Condition:
|
Completed |
Study Name: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Condition:
Interventions: |
Recruiting |
Study Name: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings Condition:
|
Active, not recruiting |
Study Name: Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Condition:
|
Completed |
Study Name: MEN-10755 in Treating Patients With Solid Tumors Condition:
Date: 1999-11-01 Interventions: Drug: sabarubicin |
Active, not recruiting |
Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition:
|
Active, not recruiting |
Study Name: Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors Condition: Germ Cell Cancer Date: 2013-04-20 Interventions: Drug: Brentuximab Vedotin Intravenous Brentuximab Vedotin at the dose of 1.8 mg/Kg every 3 weeks until d |
Active, not recruiting |
Study Name: Combination Chemotherapy in Treating Men With Germ Cell Cancer Condition:
|